Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baser, M. E.
Right arrow Articles by Evans, D. G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baser, M. E.
Right arrow Articles by Evans, D. G. R.
Related Collections
Right arrow All Oncology
Right arrow Nerve tumor
NEUROLOGY 2006;66:730-732
© 2006 American Academy of Neurology
Brief Communications

Increasing the specificity of diagnostic criteria for schwannomatosis

Michael E. Baser, PhD, J. M. Friedman, MD, PhD and D. Gareth R. Evans, MD

From Los Angeles, CA (M.E.B.); Department of Medical Genetics (J.M.F.), University of British Columbia, Vancouver, British Columbia, Canada; and Academic Department of Medical Genetics (D.G.R.E.), St. Mary's Hospital, Manchester, UK.

Address correspondence and reprint requests to Dr. Michael E. Baser, 10622 Kinnard Avenue, #203, Los Angeles, CA 90024; e-mail: michael.baser{at}verizon.net

Diagnostic criteria for schwannomatosis have been proposed in a recent consensus statement. These criteria permit schwannomatosis to be distinguished from neurofibromatosis type 2 (NF2) in most patients, but there is some clinical overlap between the two diseases. In this study, the authors use data from the population-based United Kingdom NF2 Registry to recommend modifications that increase the specificity of the schwannomatosis diagnostic criteria.

Disclosure: The authors report no conflicts of interest.

Received July 14, 2005. Accepted in final form December 1, 2005.




This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
K D Hadfield, W G Newman, N L Bowers, A Wallace, C Bolger, A Colley, E McCann, D Trump, T Prescott, and D G R Evans
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis
J. Med. Genet., June 1, 2008; 45(6): 332 - 339.
[Abstract] [Full Text] [PDF]

Home page
 BiostatisticsHome page
S. M. DeSantis, E. A. Houseman, B. A. Coull, A. Stemmer-Rachamimov, and R. A. Betensky
A penalized latent class model for ordinal data
Biostat., April 1, 2008; 9(2): 249 - 262.
[Abstract] [Full Text] [PDF]